1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 2002. 106(25): p. 3143-421.
2. Drugs.com. Atorvastatin. November 2017; Available from: https://www.drugs.com/atorvastatin.html. → McIver LA, Siddique MS. Atorvastatin. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK430779/
7. BPOM: Badan Pengawas Obat dan Makanan. Atorvastatin. 2015, 21 November 2017; http://pionas.pom.go.id/monografi/atorvastatin
9. FDA. Pregnancy and Lactation Labeling (Drugs) Final Rule. 12 March 2014; https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Labeling/ucm093307.htm
10. FDA. Liptruzet. 2013-2017, 21 November 2017; https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/200153s006lbl.pdf
13. FDA. FDA Approved Drug Products: Atorvastatin. 2017; https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=browseByLetter.page&productLetter=A&ai=0.
14. FDA. Lipitor. February 2009 21 November 2017; https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020702s057lbl.pdf
22. U.S. Food and Drug Administration (FDA). LIPITOR® (atorvastatin calcium), FDA-HIGHLIGHTS OF PRESCRIBING INFORMATION . U.S. Food and Drug Administration (FDA), 2009. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020702s056lbl.pdf